Science Outreach-YINFENG LIFE EXTENSION PROGRAM

EN丨CN

International Life Extension Research Alliance

Domestic and International Exchange Dynamics

Video Center

【The YinFeng Life Continuation Project Debuts at the 2026 Annual Meeting of the Chinese Medical Association's Medical Ethics Branch—Ethics Leading Biotech Toward Benevolent Innovation】

Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross

Yinfeng Life Science Research Institute, in Collaboration with University of Science and Technology of China, Develops CryoSIM Platform, Published in Top Analytical Chemistry Journal Revolutionizing Oocyte Membrane Permeability Analysis Technology

Public Welfare Partnership: A Special Letter from the Jinan Red Cross

Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference

【The YinFeng Life Continuation Project Debuts at the 2026 Annual Meeting of the Chinese Medical Association's Medical Ethics Branch—Ethics Leading Biotech Toward Benevolent Innovation】

2026/07/22

The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.

Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross

2026/04/24

Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.

Yinfeng Life Science Research Institute, in Collaboration with University of Science and Technology of China, Develops CryoSIM Platform, Published in Top Analytical Chemistry Journal Revolutionizing Oocyte Membrane Permeability Analysis Technology

2026/03/04

The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.

Public Welfare Partnership: A Special Letter from the Jinan Red Cross

2026/02/02

On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).

World’s First Achievement Highlights Brand Leadership

2026/01/19

In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.

Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference

2026/01/04

Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.

2026-06-05

→

"Cell Robots": Magnetic Remote-Controlled Stem Cells Promote Spinal Cord Regeneration

To move toward clinical application, the team is developing a multi-chip parallel system to boost production capacity, with potential future expansion into areas such as cardiovascular disease, tumor therapy, and wound healing. From spinal cord repair to other hard-to-treat diseases, this technology may bring new hope to countless patients.

2026-06-05

→

World’s First! Chinese Team Successfully Achieves Combined Whole Liver and Dual Kidney Xenotransplantation in a Human

Millions of people worldwide lose their lives each year due to organ shortages. This breakthrough proves that multi‑organ xenotransplantation is feasible in the complex human environment, and the Chinese team is illuminating a new dawn for the organ shortage crisis.

2026-05-29

→

Scientists Develop a 'Molecular Clock' to Predict Mammalian Aging and Lifespan

The road from the laboratory to clinical application is still long. But the advent of this 'molecular clock' has opened a new window for understanding aging and developing targeted longevity strategies. As the researchers themselves put it: 'It not only helps us better understand aging but also brings us one step closer to the goal of healthy aging.'

2026-05-29

→

Milestone in Synthetic Life: First Artificial Cells Reproduce with 'One Mother, Two Different Daughters'

As the researchers put it: "We have not only created 'living' artificial cells, but also taught them to 'reproduce' — and to give birth to two different offspring." This may well be the first step toward true synthetic life.

2026-05-22

→

World First: Breakthrough in Combined Brain-Computer Interface Therapy Enables Late-Stage Paraplegic Patient to Walk Again

From "complete paralysis" to "assisted walking," from "medical dogma" to "clinical reversal," Mr. Wang's small step represents a giant leap for China's brain science and neural repair.

2026-05-22

→

Installing a "Live" Switch for the Heart: Chinese Scientists Achieve Neural Regulation of Heartbeat in a Petri Dish for the First Time

Industry experts believe this achievement represents a critical step forward for China in the fields of cardiac organoids and regenerative medicine, bringing new hope to hundreds of millions of arrhythmia patients worldwide.